Johnson & Johnson (JNJ) Issues FY13 Earnings Guidance
Johnson & Johnson (NYSE:JNJ) issued an update on its FY13 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $5.44-5.49 for the period, compared to the Thomson Reuters consensus estimate of $5.46, StockRatingsNetwork reports.
Shares of Johnson & Johnson (NYSE:JNJ) opened at 89.80 on Tuesday. Johnson & Johnson has a 52 week low of $68.51 and a 52 week high of $94.42. The stock has a 50-day moving average of $87.71 and a 200-day moving average of $87.29. The company has a market cap of $253.1 billion and a price-to-earnings ratio of 19.93.
Johnson & Johnson (NYSE:JNJ) last released its earnings data on Tuesday, October 15th. The company reported $1.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.32 by $0.04. The company had revenue of $17.60 billion for the quarter, compared to the consensus estimate of $17.46 billion. During the same quarter in the prior year, the company posted $1.25 earnings per share. The company’s quarterly revenue was up 3.1% on a year-over-year basis. Analysts expect that Johnson & Johnson will post $5.46 EPS for the current fiscal year.
JNJ has been the subject of a number of recent research reports. Analysts at Thomson Reuters/Verus downgraded shares of Johnson & Johnson from a hold rating to a sell rating in a research note to investors on Monday. On a related note, analysts at Goldman Sachs Group Inc. upgraded shares of Johnson & Johnson from a sell rating to a neutral rating in a research note to investors on Friday. They now have a $95.00 price target on the stock, up previously from $87.00. Finally, analysts at Zacks reiterated a neutral rating on shares of Johnson & Johnson in a research note to investors on Friday, August 30th. They now have a $91.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have assigned a buy rating to the stock. The company currently has an average rating of Hold and an average price target of $88.29.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.